Source: FinSMEs
Sonara Health is a Portfolio Company of Boomerang Ventures
Sonora, a Dallas, TX-based hybrid care platform provider that integrates in-person and virtual tools to improve access and adherence to methadone treatment, received a strategic funding of an undisclosed amount.
Backers included Acumen America, Sorenson Impact Foundation, Oakwood Circle Ventures, and Boomerang Ventures, as well as existing investor First Trust Capital Partners.
The company intends to use the funds to accelerate:
- Payer engagement and government relations, to enable sustainable reimbursement for hybrid methadone models.
- Continued investment in tools that support clinical decision-making around take-home dosing, dosage strength, accelerated induction, patient education, shared goal setting, and long-term recovery planning.
- Technology-enabled medication units — both co-located and free-standing — to expand treatment access in high-need areas.
Led by CEO and Founder Michael Giles, Sonara Health improves methadone treatment through a hybrid care platform that makes it easier for people with opioid use disorder (OUD) to start and stay in treatment. By combining in-person care with virtual tools, Sonara removes common barriers, like daily clinic travel, that often affect treatment retention.
The platform also supports remote intake, telecounseling, in-app messaging, and real-time adherence insights, helping care teams stay connected to patients between visits and make more informed clinical decisions
Since launching in late 2022, Sonara has helped more than 1,000 patients across 50 clinics in 14 states stay connected and engaged in treatment, supporting both greater patient flexibility and stronger clinical oversight.
Source: FinSMEs, August 25, 2025
